Table 6.
Sensitivity and Specificity of Recent CMR Wall Imaging Studies on a Per-Patient Basis in Detecting Coronary Arterial Luminal Narrowings ≥50%
| Investigators (Reference) | n | Stress Agent | Sensitivity (%) | Specificity (%) |
|---|---|---|---|---|
| Baer et al. (150) | 23 | Dipyridamole | 78 | NA |
| Baer et al. (151)* | 32 | Dobutamine | 84 | NA |
| Hundley et al. (149) | 41 | Dobutamine and atropine | 83 | 83 |
| Jahnke et al. (152) | 40 | Dobutamine | 89 | 75 |
| Nagel et al. (148) | 172 | Dobutamine | 86 | 86 |
| Paetsch et al. (153) | 79 | Adenosine | 91 | 62 |
| Paetsch et al. (153) | 79 | Dobutamine and atropine | 89 | 81 |
| Paetsch et al. (154) | 150 | Dobutamine | 78 | 88 |
| Pennell et al. (155) | 40 | Dipyridamole | 62 | 100 |
| Pennell et al. (156) | 25 | Dobutamine | 91 | 100 |
| Rerkpattanapipat et al. (157) | 27 | Exercise | 79 | 85 |
| Schalla et al. (158) | 22 | Dobutamine | 81 | 83 |
| van Rugge et al. (159) | 45 | Dobutamine | 81 | 100 |
| van Rugge et al. (160) | 39 | Dobutamine | 91 | 0.83 |
CMR indicates cardiovascular magnetic resonance; and NA, not available.
*
Utilized 2 perfusion territories (left anterior descending coronary artery and combined left circumflex artery/right coronary artery. Modified from Nandalur et al. (146).